SEARCH

SEARCH BY CITATION

References

  • Angelopoulou, M.K., Nademanee, A., Dagis, A., Molina, A., Fung, H., Parker, P., O'Donnell, M.R., Stein, A., Falk, P., Krishnan, A., Kogut, N., Rodriguez, R., Sahebi, F., Smith, E.P., Snyder, D., Spielberger, R., Zain, J., Popplewell, L., Smith, D. & Forman, S.J. (2003) Comparison of outcome of high dose chemotherapy (HDT) and autologous stem cell transplantation (ASCT) in peripheral T-cell lymphoma (PTCL) vs. diffuse large B cell lymphoma (B-DLCL). Blood, 102, 247a.
  • Arrowsmith, E.R., Macon, W.R., Kinney, M.C., Stein, R.S., Goodman, S.A., Morgan, D.S., Flexner, J.M., Cousar, J.B., Jagasia, M.H., McCurley, T.L. & Greer, J.P. (2003) Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leukemia & Lymphoma, 44, 241249.
  • Ascani, S., Zinzani, P.L., Gherlinzoni, F., Sabattini, E., Briskomatis, A., De Vivo, A., Piccioli, M., Fraternali Orcioni, G., Pieri, F., Goldoni, A., Piccaluga, P.P., Zallocco, D., Burnelli, R., Leoncini, L., Falini, B., Tura, S. & Pileri, S.A. (1997) Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L Classification. Annals of Oncology, 8, 583592.
  • Blystad, A.K., Enblad, G., Kvaloy, S., Berglund, A., Delabie, J., Holte, H., Carlson, K., Kvalheim, G., Bengtsson, M. & Hagberg, H. (2001) High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplantation, 27, 711716.
  • Caballero, M.D., Perez-Simon, J.A., Iriondo, A., Lahuerta, J.J., Sierra, J., Marin, J., Gandarillas, M., Arranz, R., Zuazu, J., Rubio, V., Fernandez de Sevilla, A., Carreras, E., Garcia-Conde, J., Garcia-Larana, J., Grande, C., Sureda, A., Vidal, M.J., Rifon, J., Perez-Equiza, C., Varela, R., Moraleda, J.M., Garcia Ruiz, J.C., Albo, C., Cabrera, R., San Miguel, J.F. & Conde, E. (2003) High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Annals of Oncology, 14, 140151.
  • Cox, D. (1972) Regression models and life-tables. Journal of the Royal Statistical Society, Series B, 34, 187220.
  • Falini, B., Pileri, S., Zinzani, P.L., Carbone, A., Zagonel, V., Wolf-Peeters, C., Verhoef, G., Menestrina, F., Todeschini, G., Paulli, M., Lazzarino, M., Giardini, R., Aiello, A., Foss, H.-D., Araujo, I., Fizzotti, M., Pelicci, P.-G., Flenghi, L., Martelli, M.F. & Santucci, A. (1999) ALK+ lymphoma: clinico-pathological findings and outcome. Blood, 93, 26972706.
  • Gascoyne, R.D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B.F., Greiner, T.C., Morris, S.W., Connors, J.M., Vose, J.M., Viswanatha, D.S., Coldman, A. & Weisenburger, D.D. (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood, 93, 39133921.
  • Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals-Hatem, D., Bosly, A., Xerri, L., Tilly, H., Berger, F., Bouhabdallah, R. & Diebold, J. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, 7682.
  • Hamlin, P.A., Zelenetz, A.D., Kewalramani, T., Qin, J., Satagopan, J.M., Verbel, D., Noy, A., Portlock, C.S., Straus, D.J., Yahalom, J., Nimer, S.D. & Moskowitz, C.H. (2003) Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood, 102, 19891996.
  • Hoerr, A.L., Gao, F., Hidalgo, J., Tiwari, D., Blum, K.A., Mathews, V., Adkins, D.R., Blum, W., Devine, S., Vij, R., Goodnough, L.T., Dipersio, J.F. & Khoury, H.J. (2004) Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma. Journal of Clinical Oncology, 22, 45614566.
  • Horwitz, S.M., Negrin, R.S., Blume, K.G., Breslin, S., Stuart, M.J., Stockerl-Goldstein, K.E., Johnston, L.J., Wong, R.M., Shizuru, J.A. & Horning, S.J. (2004) Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood, 103, 777783.
  • Intragumtornchai, T., Rotnakkarin, P., Sutcharitchan, P. & Wannagrairoj, P. (2003) Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma. Clinical Lymphoma, 4, 5255.
  • Jaffe, E., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon.
  • Jagasia, M., Morgan, D., Goodman, S., Hamilton, K., Kinney, M., Shyr, Y., Stein, R., Zic, J. & Greer, J. (2004) Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leukemia & Lymphoma, 45, 22612267.
  • Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kewalramani, T., Zelenetz, A.D., Hedrick, E.E., Donnelly, G.B., Hunte, S., Priovolos, A.C., Qin, J., Lyons, N.C., Yahalom, J., Nimer, S.D. & Moskowitz, C.H. (2000) High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood, 96, 23992404.
  • Kewalramani, T., Zelenetz, A.D., Nimer, S.D., Portlock, C., Straus, D., Noy, A., O'Connor, O., Filippa, D.A., Teruya-Feldstein, J., Gencarelli, A., Qin, J., Waxman, A., Yahalom, J. & Moskowitz, C.H. (2004) Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood, 103, 36843688.
  • Lopez-Guillermo, A., Cid, J., Salar, A., Lopez, A., Montalban, C., Castrillo, J.M., Gonzalez, M., Ribera, J.M., Brunet, S., Garcia-Conde, J., Fernandez de Sevilla, A., Bosch, F. & Montserrat, E. (1998) Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L Classification. Annals of Oncology, 9, 849855.
  • Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163170.
  • Melnyk, A., Rodriguez, A., Pugh, W.C. & Cabannillas, F. (1997) Evaluation of the revised European–American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood, 89, 45144520.
  • Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. & Linet, M.S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood, 107, 265276.
  • Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.Y., Colombat, P., Goldstone, A.H., Gorin, N.C. & Flesh, M. (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316, 14931498.
  • Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. & Harousseau, J.L. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 15401545.
  • Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F.B., Younes, A., Andersson, B., Giralt, S., Gajewski, J., De Lima, M., Couriel, D., Romaguera, J., Cabanillas, F.F., Champlin, R.E. & Khouri, I.F. (2001) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. Journal of Clinical Oncology, 19, 37663770.
  • Rodriguez, J., Caballero, M.D., Gutierrez, A., Marin, J., Lahuerta, J.J., Sureda, A., Carreras, E., Leon, A., Arranz, R., Fernandez de Sevilla, A., Zuazu, J., Garcia-Larana, J., Rifon, J., Varela, R., Gandarillas, M., SanMiguel, J. & Conde, E. (2003) High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Annals of Oncology, 14, 17681775.
  • Rosner, B. (1994) Hypothesis testing: categorical data. In: Fundamentals of Biostatistics, pp. 345442. Wadsworth, Belmont, CA.
  • Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., Mikata, A., Nanba, K., Takami, T., Yamabe, H., Takano, Y., Izumo, T., Nagatani, T., Mohri, N., Nasu, K., Satoh, H., Katano, H., Fujimoto, J., Yamamoto, T. & Mori, S. (1995) Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood, 86, 19541960.
  • Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T. & Coiffier, B. (1999) International Consensus Conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. Journal of Clinical Oncology, 17, 423429.
  • Song, K.W., Mollee, P., Keating, A. & Crump, M. (2003) Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology, 120, 978985.
  • The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood, 89, 39093918.
  • Vose, J.M., Peterson, C., Bierman, P.J., Weisenburger, D.D., Linder, J., Harrington, D., Vaughan, W.P., Kessinger, A. & Armitage, J.O. (1990) Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood, 76, 424431.